- Previous Close
0.8400 - Open
0.8400 - Bid 0.8350 x --
- Ask 0.8400 x --
- Day's Range
0.8350 - 0.8400 - 52 Week Range
0.7700 - 1.4000 - Volume
26,130 - Avg. Volume
159,022 - Market Cap (intraday)
109.388M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0500 - Earnings Date Aug 23, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
0.99
Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research. The company was founded in 2001 and is based in Perth, Australia.
www.proteomics.com.auRecent News: PIQ.AX
View More
Performance Overview: PIQ.AX
Trailing total returns as of 8/29/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PIQ.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PIQ.AX
View MoreValuation Measures
Market Cap
110.04M
Enterprise Value
103.72M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
118.49
Price/Book (mrq)
11.69
Enterprise Value/Revenue
116.26
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-178.80%
Return on Assets (ttm)
-38.49%
Return on Equity (ttm)
-73.77%
Revenue (ttm)
3.57M
Net Income Avi to Common (ttm)
-6.38M
Diluted EPS (ttm)
-0.0500
Balance Sheet and Cash Flow
Total Cash (mrq)
6.64M
Total Debt/Equity (mrq)
3.42%
Levered Free Cash Flow (ttm)
-3.43M